Log In
Print
BCIQ
Print
Print this Print this
 

Kynamro, mipomersen (ISIS 301012 subcutaneous)

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionSecond-generation antisense inhibitor of Apolipoprotein B-100 (APOB-100) mRNA
Molecular Target Apolipoprotein B-100 (APOB-100) mRNA
Mechanism of ActionAntisense therapy
Latest Stage of DevelopmentApproved
IndicationHypercholesterolemia
Partner

Sanofi
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today